HCPCS - General Information

What's New

PUBLICATION OF CODING DECISIONS FOR Q2 2022 HCPCS LEVEL II DRUG and BIOLOGICAL APPLICATIONS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter two (Q2) 2022 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes the Q2 2022 HCPCS Level II applications for drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ October 2022 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

HCPCS PUBLIC MEETING MATERIALS

CMS is announcing the publication of its First Biannual (B1) 2022 HCPCS Public Meeting Agendas for its June 7-10 2022, Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS recommends interested parties refer to the Guidelines for Participation in HCPCS Public Meetings for June 2022, which are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

The guidelines contain important and useful information, such as instructions for registering to attend the B1 2022 HCPCS Public Meeting; instructions for registering as a primary speaker or a 5-minute speaker; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline to register as a speaker is Tuesday, May 24, 2022, at 5:00 p.m., eastern daylight time (e.d.t.). All speakers must register online, identify as a primary speaker or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/meeting/register/vJIsd-mgpz4jEvObPtTKB0-BGiFBQ80CuHQ. Primary speakers are permitted to submit written presentation materials, which are also due no later than Tuesday, May 24, 2022, at 5:00 p.m., e.d.t.

Additionally, CMS notes that the B1 2022 HCPCS Public Meeting on June 7-10 will include preliminary benefit category and payment determinations for codes effective January 1, 2020 to April 1, 2022, continuous glucose monitoring coding and payment determinations, and additional items added by CMS to address Medicare benefit category or payment determinations.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR Q1 2022 APPLICATION CYCLE FOR DRUG AND BIOLOGICALS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter one (Q1) 2022 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q1 2022 applications for HCPCS Level II drug and biological coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ July 2022 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

HCPCS Webpage Updates

As all HCPCS Level II updates are now fully searchable and sortable electronic files, CMS will no longer publish the Table of Drugs and HCPCS Index as part of the HCPCS quarterly updates.

Additionally, due to the establishment of complete HCPCS quarterly files beginning in 2020, CMS is removing the “Other Codes (other than C and G HCPCS codes)” section from the HCPCS Quarterly Update page. The information contained in this section has been incorporated into annual HCPCS file for the appropriate year.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR Q4 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for quarter four (Q4) 2021 Drugs and Biologics at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q4 2021 applications for HCPCS Level II drug and biologic coding requests. For each application, the following information is provided:

a statement of the topic/issue;
a summary of the applicant’s request; and
CMS’ coding decision.

Please continue to monitor this web site for CMS’ April 2022 HCPCS Update file, which will be published separately in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update.

PUBLICATION OF CMS HCPCS LEVEL II APPLICATION SUMMARIES AND CODING DECISIONS FOR THE B2 2021 CODING CYCLE

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for the second biannual (B2) 2021 coding cycle at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a listing of applications brought to the HCPCS Level II Public Meeting on December 1-2, 2021. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; CMS’ preliminary HCPCS coding recommendation; a summary of the primary speaker’s comments at the public meeting, and CMS’ final coding decision.

ANNOUNCEMENT OF UPCOMING CODING CYCLE DEADLINES

CMS is announcing that the HCPCS Level II application submission deadline for the third quarterly (Q3) and second biannual (B2) 2022 coding cycles is July 5, 2022, and the submission deadline for the fourth quarterly (Q4) 2022 coding cycle is October 3, 2022.

The electronic application intake system, Medicare Electronic Application Request Information System (MEARIS^TM), is available for HCPCS Level II application submission. The CMS HCPCS Level II Modification to Code Set Form can be accessed at: https://mearis.cms.gov/public/home.

CMS will only accept HCPCS Level II applications submitted via MEARIS^TM.

PUBLICATION OF UPDATED ZOOM LINK FOR DECEMBER 1 AND DECEMBER 2, 2021 HCPCS PUBLIC MEETINGS

Please be advised that due to technical difficulties, the Zoom link that you have received for December 1 and December 2, 2021 HCPCS public meetings is NO LONGER VALID.

The new Zoom link, for December 1 and December 2, 2021 HCPCS public meetings is: https://cms.zoomgov.com/meeting/vJItf-qvpjwjE12CS2nKqOFFAbV9ICKNPkc/ics?icsToken=98tyKuiurjMpHdySuRDBeI89EMH8aOvrlXtr-_F-r03rKDF8RCXXNNQbG5FUPujb

Join ZoomGov Meeting

https://cms.zoomgov.com/j/1608378799?pwd=SDRNR3UveUZ1M2ZKWFFLb3ovbDR6QT09

Meeting ID: 160 837 8799

Password: 938840

Dial by your location

+1 669 254 5252 US (San Jose)

+1 646 828 7666 US (New York)

833 568 8864 US Toll-free

Meeting ID: 160 837 8799

PUBLICATION OF PUBLIC MEETING MATERIALS FOR THE 2021 BIANNUAL HCPCS CODING CYCLE

CMS is announcing the publication of its HCPCS Public Meeting Agendas for its December 1-2 2021, Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS also reminds interested parties about the 2021 B2 Guidelines in HCPCS Public Meetings. These guidelines can be viewed and downloaded at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

The guidelines contain important and useful information, such as instructions for registering to attend public meetings; instructions for registering as a primary speaker or a 5-minute speaker; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline for the public meeting registration and primary speaker materials is Wednesday, November 17, 2021, at 5:00 p.m., est. All speakers must register online, identify as a primary or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/meeting/register/vJItf-mtpjsrGmPUe9EFh3kSrpwZX1tVtVE.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR TEN 510(K)-CLEARED WOUND CARE PRODUCTS PROCESSED DURING CMS’ 2020 AND 2021 HCPCS CODE APPLICATION REVIEW CYCLES.

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) coding decisions for ten 510(k)-cleared wound care products processed during CMS’ 2020 and 2021 HCPCS code application review cycles. It also includes one HCPCS code application and CMS’ HCPCS coding decision for a product that qualifies for the Transitional Adjustment for New and Innovative Equipment and Supplies under the End-Stage Renal Disease Prospective Payment System.

Applications for ten 510(k)-cleared wound care products https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

Please continue to monitor this web site for CMS’ January 2022 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/HCPCS-Quarterly-Update

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR THIRD QUARTER (Q3), 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) Application Summary for Q3 Drugs and Biologics at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q3 2021 applications for HCPCS Level II drug and biologic coding requests. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; and CMS’ coding decision.

PUBLIC NOTIFICATION OF NEW HCPCS LEVEL II APPLICATION SUBMISSION PROCESS

The electronic application intake system, Medicare Electronic Application Request Information System (MEARIS^TM), is available for HCPCS Level II Q4 2021 and B1 2022 application submissions, with application submissions due no later than September 20, 2021 and January 4, 2022, respectively. The HCPCS Level II Application form designed for MEARIS^TM is similar to the current OMB-approved paper application (CMS-10224, OMB-0938-1042). The CMS HCPCS Level II Modification to Code Set Form can be accessed at: https://mearis.cms.gov/public/home.

Moving forward, CMS will only accept HCPCS Level II applications submitted via MEARIS^TM. Applications submitted through the HCPCS application mailbox will no longer be considered. Within MEARIS^TM, we have built in several resources to support applicants:

Please refer to the “Resources” section for guidance regarding the application submission process at: https://mearis.cms.gov/public/resources.
Technical support is available under “Useful Links” at the bottom of the MEARIS^TM
Application related questions can be submitted to CMS using the form available under “Contact” at: https://mearis.cms.gov/public/resources?app=HCPCS.
The time required for application submission, including the time needed to gather relevant information as well as to complete the form, is estimated to be roughly around 10 hours per submission. Applicants are, therefore, encouraged to start in advance of the due date to ensure adequate time for submission.

Application submission through MEARIS^TMwill not only help CMS track applications and streamline the review process, but it will also create efficiencies for applicants when compared to the previous paper submission process.

ANNOUNCEMENT OF UPCOMING CODING CYCLE DEADLINES

CMS is announcing that the HCPCS Level II application submission deadline for the first quarterly (Q1) and first biannual (B1) 2022 coding cycles is January 4, 2022, and the submission deadline for the second quarterly (Q2) 2022 coding cycle is April 1, 2022.

Please refer to the public notification of the new HCPCS Level II application submission process on this web page for further information regarding application submission for the upcoming coding cycles.

PUBLICATION OF CMS HCPCS LEVEL II APPLICATION SUMMARIES AND CODING DECISIONS FOR THE FIRST BI-ANNUAL (B1), 2021 CODING CYCLE

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Decisions for the B1 2021 coding cycle at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a listing of applications brought to the HCPCS Public Meeting on July 7-8, 2021. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; CMS’ preliminary HCPCS coding recommendation; a summary of primary speaker comments at the public meeting, and CMS’ final coding decision.

Please continue to monitor this web site for CMS October 2021 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR SECOND QUARTER (Q2), 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICS

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce publication of its 2021 Healthcare Common Procedure Coding System (HCPCS) Application Summary for Q2 Drugs and Biologics at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of Q2 2021 applications for HCPCS Level II drug and biologic coding requests. For each application, the following information is provided: a statement of the topic/issue; a summary of the applicant’s request; and CMS’ coding decision.

PUBLICATION OF PUBLIC MEETING MATERIALS FOR THE FIRST 2021 BIANNUAL HCPCS CODING CYCLE

CMS is announcing the publication of its HCPCS Public Meeting Agendas for its July 7-9, 2021 Virtual HCPCS Public Meeting. The agendas are available at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS notes that although we have announced that the virtual public meeting will be held over a period of three days, we have arranged the preliminary coding recommendations we intend to discuss over a period of two days; July 7 and 8. If we receive a greater number of speaker registrations than we believe we can reasonably accommodate over those two days, we reserve the right to shift some agenda items to a third day, July 9. In that eventuality, we would make every effort to notify all affected speakers as soon as possible, in addition to posting all updates on CMS’ HCPCS website at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.

CMS also reminds interested parties about the “Guidelines for Participation in Virtual Public Meetings in July 2021 for New Revisions to the Healthcare Common Procedure Coding System (HCPCS) Code Set.” These guidelines can be viewed and downloaded at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

The deadline for the public meeting registration and primary speaker materials is Friday, June 25, 2021, at
5:00 p.m., e.d.t. All speakers must register online, identify as a primary or a 5-minute speaker, and provide the requested contact information at: https://cms.zoomgov.com/webinar/register/WN_ukTCxcctSReHO2RJaD5O6w.

The Zoom link, for the July 7-9, 2021 public meeting is: https://cms.zoomgov.com/webinar/register/WN_ukTCxcctSReHO2RJaD5O6w.

PUBLICATION OF REVISED CMS HCPCS LEVEL II CODE DECISIONS FOR FIRST QUARTER (Q1), 2021 APPLICATION CYCLE FOR DRUGS AND BIOLOGICS

The 2021 HCPCS Application Summary for Q1 Cycle for Drugs and Biologics was updated on 05/26/2021 to reflect a correction to the code number previously published to identify Kcentra. The final, corrected code assignment is J7168, as specified in the FINAL DECISION for item 21.008 in the 2021 HCPCS Application Summary for Quarter 1, 2021 Drugs and Biologics document. Code number J7168 replaces code J7169, which was previously published in error.

The revised HCPCS Level II code decisions and application summary documents for First Quarterly Cycle for Drugs and Biologics may be downloaded at:

https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR FIRST QUARTER (Q1), 2021 APPLICATION CYCLE FOR DRUG AND BIOLOGICAL PRODUCTS

The Centers for Medicare & Medicaid Services (CMS) has updated its Healthcare Common Procedural Coding System (HCPCS) Level II coding procedures to enable shorter and more frequent HCPCS code application cycles. CMS has implemented quarterly HCPCS code application opportunities for drugs and biological products; and bi-annual application opportunities for durable medical equipment, orthotics, prosthetics and supplies, and other non-drug, non-biological products, as part of our comprehensive initiative to foster innovation and expedite adoption of and patient access to new medical technologies.

CMS is pleased to announce publication of its 2021 HCPCS Application Summary for Q1 Drugs and Biologicals at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of applications for HCPCS codes for drug and biological products submitted to CMS’ First Quarterly coding cycle of 2021 (Q1 2021). For each application, the following information is provided: a statement of the incoming request; a summary of the applicant’s request; and CMS’ coding decision.

Please continue to monitor this web site for CMS July 2021 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS

PUBLICATION OF REVISED HCPCS LEVEL II CODE MODIFICATION APPLICATION FORM AND INSTRUCTIONS FOR 2021 CODING CYCLE AND HCPCS LEVEL II CODING PROCEDURES DOCUMENTS

CMS has revised its Healthcare Common Procedure Coding System (HCPCS) Level II Code Modification Application Form and Instructions document and HCPCS Level II Coding Procedures document to update the HCPCS Level II code application submission deadlines, contact information, and public meeting schedule for the upcoming 2021 coding cycles.

PUBLICATION OF CMS HCPCS LEVEL II CODE DECISIONS FOR FOURTH QUARTER (Q4), 2020 APPLICATION CYCLE FOR DRUG AND BIOLOGICAL PRODUCTS AND SECOND BI-ANNUAL 2020 CODING CYCLE (B2), FOR NON-DRUG AND NON-BIOLOGICAL ITEMS AND SERVICES

The Centers for Medicare & Medicaid Services (CMS) is updating its Healthcare Common Procedural Coding System (HCPCS) Level II coding procedures to enable shorter and more frequent HCPCS code application cycles. CMS has implemented quarterly HCPCS code application opportunities for drugs and biological products; and bi-annual application opportunities for durable medical equipment, orthotics, prosthetics and supplies, and other non-drug, non-biological products, as part of our comprehensive initiative to foster innovation and expedite adoption of and patient access to new medical technologies.

CMS is pleased to announce publication of its 2020 HCPCS application summaries for Q4 drugs and biologicals and our second bi-annual 2020 coding cycle (B2) for non-drug and non-biological items and services at: https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/Prior-Years-CMS-HCPCS-LevelII-Coding-Decisions-Narrative-Summary.

This narrative summary document includes a sequential listing of applications for HCPCS codes for drug and biological products submitted to CMS’ Fourth Quarterly coding cycle of 2020 (Q4 2020) and non-drug and non-biological items and services applications submitted to CMS’ second bi-annual coding cycle of 2020 (B2). For each application for drug and biological products, the following information is provided: a statement of the incoming request, a summary of the applicant’s request, and CMS’ coding decision. For each application for non-drug and non-biological items and services, the following information is provided: a statement of the incoming request, a summary of the applicant’s request, a preliminary HCPCS coding recommendation, a summary of primary speaker comments at the public meeting, and CMS’ coding decision.

Please continue to monitor this web site for CMS April 2021 HCPCS Update file, which will be published separately, in the coming weeks, at: https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS.

CMS is announcing publication of its HCPCS Public Meeting Agendas for its December 21 and December 22, 2020 Virtual HCPCS Public Meetings for Non-Drug and Non-Biological Items and Services. The agendas are available at https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

CMS is announcing the deadline for submission of new HCPCS code applications:

The deadline for submission of new HCPCS code applications for 2021 1^st quarterly cycle for Drugs and Biologicals is January 4, 2021.

The deadline for submission of new HCPCS code applications for 2021 1^st bi-annual cycle for DMEPOS and Other Non-Drug, Non-Biological Coding Cycles is January 4, 2021.

The deadline for submission of new HCPCS code applications for 2021 2^ndquarterly cycle for Drugs and Biologicals is April 1, 2021.

Due to the COVID-19 Public Health Emergency and related restrictions on public gatherings, the December 2020 HCPCS Public Meetings will be held virtually via Zoom for remote attendance only.

Note that during the December 22, 2020, Public Meeting, in addition to information pertaining to current applications for DMEPOS and other non-drug and non-biological items, CMS is also including information pertaining to the establishment of three new codes K1010 (Indwelling intraurethral drainage device with valve, replacement only, each), K1011 (Activation device for intraurethral drainage device with valve, replacement only, each), and K1012 (Charger and base station for intraurethral activation device, replacement only). We are interested in gathering additional input pertaining to use of these codes. Please refer to the December 22, 2020 HCPCS Public Meeting agenda for additional information.

CMS also reminds interested parties about the “2020 Guidelines for Participation in Virtual Public Meetings for New Public Requests for Revisions to the Healthcare Common Procedure Coding System (HCPCS)”. These guidelines can be viewed and downloaded at https://www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings

These guidelines contain important and useful information such as instructions for registering to attend public meetings; instructions for registering as a primary speaker or a 5-minute speaker; guidelines for participation in public meetings; deadlines for registration and materials submission; and tips for helping CMS conduct a productive meeting.

The deadline for the public meeting registration and primary speaker materials is December 17, 2020, at 5 pm ET.

All speakers must register online, identify as a primary or 5-minute speaker, and provide the requested contact information at https://www.cms.gov/events. Registration is necessary in order for speakers to receive their participant ID.

The Zoom link, for December 21 and December 22, 2020 public meetings: https://cms.zoomgov.com/j/1610701817?pwd=R3hYaWtPaGVVREh2YVNMSkFQMThEQT09.

HCPCS Background Information

Each year, in the United States, health care insurers process over 5 billion claims for payment. For Medicare and other health insurance programs to ensure that these claims are processed in an orderly and consistent manner, standardized coding systems are essential. The HCPCS Level II Code Set is one of the standard code sets used for this purpose. The HCPCS is divided into two principal subsystems, referred to as level I and level II of the HCPCS. Level I of the HCPCS is comprised of CPT (Current Procedural Terminology), a numeric coding system maintained by the American Medical Association (AMA). The CPT is a uniform coding system consisting of descriptive terms and identifying codes that are used primarily to identify medical services and procedures furnished by physicians and other health care professionals. These health care professionals use the CPT to identify services and procedures for which they bill public or private health insurance programs. Decisions regarding the addition, deletion, or revision of CPT codes are made by the AMA. The CPT codes are republished and updated annually by the AMA. Level I of the HCPCS, the CPT codes, does not include codes needed to separately report medical items or services that are regularly billed by suppliers other than physicians.

Level II of the HCPCS is a standardized coding system that is used primarily to identify products, supplies, and services not included in the CPT codes, such as ambulance services and durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) when used outside a physician's office. Because Medicare and other insurers cover a variety of services, supplies, and equipment that are not identified by CPT codes, the level II HCPCS codes were established for submitting claims for these items. The development and use of level II of the HCPCS began in the 1980's. Level II codes are also referred to as alpha-numeric codes because they consist of a single alphabetical letter followed by 4 numeric digits, while CPT codes are identified using 5 numeric digits.

Downloads

Page Last Modified:

07/06/2022 05:26 PM

Help with File Formats and Plug-Ins

HCPCS - General Information

What's New

HCPCS Background Information

Downloads

Related Links